CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Amyotrophic Lateral Sclerosis
Related studies linked through entity extraction aliases.
MIROCALS: Modifying Immune Response and OutComes in ALS
- Status
- COMPLETED
- Phase
- PHASE2
NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)
- Status
- WITHDRAWN
- Phase
- NA
A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)
- Status
- TERMINATED
- Phase
- NA
ALS Testing Through Home-based Outcome Measures
- Status
- COMPLETED
- Phase
- N/A
Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Delineating Swallowing Impairment and Decline in ALS
- Status
- COMPLETED
- Phase
- N/A
CNS10-NPC-GDNF for the Treatment of ALS
- Status
- COMPLETED
- Phase
- PHASE1
Diaphragmatic Pacer Placement: Anesthetic Management (DP)
- Status
- COMPLETED
- Phase
- N/A
Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Environmental Exposure and Neurological Diseases Questionnaire
- Status
- COMPLETED
- Phase
- N/A
Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis
- Status
- UNKNOWN
- Phase
- PHASE1
Therapeutic Treatment of Amyotrophic Lateral Sclerosis
- Status
- UNKNOWN
- Phase
- PHASE1
Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes
- Status
- COMPLETED
- Phase
- NA
Noninvasive Assessment of Neuronal Damage by MRI Sodium ( 23Na ) in Amyotrophic Lateral Sclerosis
- Status
- UNKNOWN
- Phase
- NA
Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND
- Status
- COMPLETED
- Phase
- PHASE1
Amyotrophic Lateral Sclerosis and the Innate Immune System
- Status
- RECRUITING
- Phase
- N/A
Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis (ALS).
- Status
- COMPLETED
- Phase
- PHASE2